Who
Joshua J. Ofman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Grail.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $36.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Jun 2024
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $53K400 at $133.12 | filing |
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $134K1,000 at $134.38 | filing |
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $461K3,400 at $135.44 | filing |
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $965K7,052 at $136.83 | filing |
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $830K6,034 at $137.63 | filing |
| 15 Oct 2026filed 16 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $293K2,114 at $138.79 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Code M | $370K26,452 at $14.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL Grailoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —26,452 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $196K2,125 at $92.32 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $136K1,454 at $93.61 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL Grailoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —26,452 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $3.6M37,752 at $94.98 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $598K6,200 at $96.43 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $137K1,400 at $97.84 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $42K421 at $99.85 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $211K2,100 at $100.68 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $1.1M10,000 at $110.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Code M | $370K26,452 at $14.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $196K2,125 at $92.32 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $136K1,454 at $93.61 | filing |
News
GRAIL (NASDAQ:GRAL) CEO Joshua Ofman Sells 20,000 Shares of StockGRAL · dailypolitical.com · 17 Oct 2026Jim Cramer Breaks Down the Stakes in Detail as GRAIL (GRAL) Awaits Its Next Big DecisionGRAL · insidermonkey.com · 10 Oct 2026
0 headlines in the last 90 days name Joshua J. Ofman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.